BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 21, 2018
View Archived Issues
The point of disorder
Read More
How S. pneumonia PLYs its deadly trade
Read More
Phase I/II study of novel CAR T-cell therapy is enrolling patients with leukemia or lymphoma
Read More
Patient recruitment ongoing in phase II study of SHR-1210 plus BP-102 and Xelox in mCRC
Read More
AbbVie initiates phase I study of SC-011 as single agent and in combination with ABBV-181
Read More
Nutlin-based PROTAC knockdowns target protein and upregulate p53, decreasing cancer cell viability
Read More
Rat model of heritable pulmonary arterial hypertension created with Bmpr2 missense mutation
Read More
Identification of small-molecule RPA inhibitors targeting DNA damage response for cancer treatment
Read More
Splice variant in HSD17B13 protects against histological damage in NAFLD patients from South America
Read More
Phase I study evaluates mogamulizumab with durvalumab or tremelimumab in advanced solid tumors
Read More
Study links receptor mutations, calcium signaling, spinocerebellar ataxias
Read More
Toray announces an agreement to develop TRK-880
Read More
IMV amends phase Ib/II study to develop DPX-Survivac as monotherapy for recurrent ovarian cancer
Read More
U.S. researchers patent ACVR1 inhibitors
Read More
Harvard College and Macrolide Pharmaceuticals present new antibacterials
Read More
Mochida Pharmaceutical identifies new NTRK1 inhibitors
Read More
Horitzonts Tecnologics Hungary Kft synthesizes new compounds for infections
Read More
GEn1E Lifesciences enters option agreement to license University of Maryland's MUC-ED peptide
Read More
FDA approves Gamifant for primary hemophagocytic lymphohistiocytosis
Read More
Sparing the liver with a new strategy to activate TNFRSF10B
Read More
Aurigene presents the discovery of novel dual inhibitors of CD73 and A2AR
Read More
MM-401 demonstrates robust responses in multiple syngeneic mouse tumor models
Read More
biOasis reports data from study examining whole-body distribution of xB3-001
Read More
Tremfya receives additional indication approval as first biologic agent for palmoplantar pustulosis
Read More
Auris holds pre-IND meeting with FDA for AM-201 to prevent olanzapine-induced weight gain
Read More